Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,912Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12SK LIFE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

CENOBAMATE

US Patent Number : 11654133

Drug Substance Claim :

Drug Product Claim :

Application Number : 212839

Patent Use Code : U-3610

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-06-16

blank

02

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

CENOBAMATE

US Patent Number : 11654133

Drug Substance Claim :

Drug Product Claim :

Application Number : 212839

Patent Use Code : U-3610

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-06-16

blank

03

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

CENOBAMATE

US Patent Number : 11654133

Drug Substance Claim :

Drug Product Claim :

Application Number : 212839

Patent Use Code : U-3610

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-06-16

blank

04

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

CENOBAMATE

US Patent Number : 11654133

Drug Substance Claim :

Drug Product Claim :

Application Number : 212839

Patent Use Code : U-3610

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-06-16

blank

05

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

CENOBAMATE

US Patent Number : 11654133

Drug Substance Claim :

Drug Product Claim :

Application Number : 212839

Patent Use Code : U-3610

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-06-16

blank

06

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

CENOBAMATE

US Patent Number : 11654133

Drug Substance Claim :

Drug Product Claim :

Application Number : 212839

Patent Use Code : U-3610

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-06-16

blank

07

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

CENOBAMATE

US Patent Number : 7598279

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 212839

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-10-30

blank

08

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

CENOBAMATE

US Patent Number : 7598279

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 212839

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-10-30

blank

09

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

CENOBAMATE

US Patent Number : 7598279

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 212839

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-10-30

blank

10

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

CENOBAMATE

US Patent Number : 7598279

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 212839

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-10-30

blank